GlaxoSmithKline Passes This Key Test

 There's no foolproof way to know the future for GlaxoSmithKline (NYSE: GSK) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.